HIGHLIGHTS
- who: Opinion and collaborators from the University of Coimbra, Portugal Xcenda GmbH, Germany have published the research work: Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts, in the Journal: (JOURNAL)
- how: This aims to explore patients' concerns and familiarize them with the research that utilized their data.
SUMMARY
COPYRIGHT Frontiers in Pharmacology Apart from its traditional use in the post-authorization phase for safety assessment, risk management, and life cycle benefit-risk evaluation (Flynn . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.